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Abstract
Background: Somatic comorbidity in patients with depression and anxiety is very prevalent and mainly studied with respect
to chronic conditions. Patients with mental health problems are high utilizers of medical care. This may be a result of their
functional impairment and illness behaviour, but also of their interpretation of common symptoms and their attitude
towards healthcare. Therefore, we expect that patients with mental health problems are more likely to present with minor
illnesses to the general practitioner. Objective: To assess the association of minor illnesses with depression and anxiety.
Methods: A historic cohort study in a general practice database of 13 500 patients, with more than 30 years’ follow-up. Three
prevalent categories of minor illnesses were assessed: skin, musculoskeletal, and respiratory disorders. We studied the
number of patients with a diagnosis of a minor illness in patients with depression and anxiety disorder compared with their
matched controls. Results: We found 799 patients with depression and 153 patients with anxiety disorder. More patients with
depression present skin, musculoskeletal, and respiratory disorders in the year before and the years following the initial
diagnosis of depression. Depression appeared to be statistically significantly associated with presenting all three types of
minor illnesses. More patients with anxiety disorder present skin and respiratory disorders in the year before diagnosis, and
more musculoskeletal disorders in the years following the diagnosis of anxiety disorder. Anxiety disorder appeared to be
statistically significantly associated with presenting skin and musculoskeletal morbidity.
Conclusion: Compared to controls, more patients with depression and anxiety disorder present minor illnesses. This could
be due to their high attendance rate, altered illness behaviour, or to factors*e.g., stress*underlying both the development
of depression or anxiety and the susceptibility to diseases.
Key words: Depression, anxiety disorders, comorbidity, minor illness, illness, behaviour, coping
Cases
Ms W contacts her general practitioner (GP) due to
rhino sinusitis, which has been bothering her for about 3
days. In her medical history, an anxiety disorder is
mentioned.
Mr D consults his GP for muscle pain in both arms,
which has been present for 5 days. He was diagnosed with
a major depression 8 years ago.
Most patients with symptoms of rhino sinusitis or
muscle pain do not tend to consult their GP immediately.
For most patients, rhino sinusitis and muscle pain are
minor illnesses. Are patients with a history of depression
or anxiety disorder more likely to consult for minor
illnesses?
Introduction
General practitioners (GPs) take care of their
patients over a long period of time for a broad
variety of medical conditions, varying from rhino
sinusitis and backache to chronic diseases such as
diabetes mellitus and chronic obstructive pulmonary
disease (COPD). GPs care for patients with a wide
range of diseases and illnesses, and all kinds of
combinations of diseases (i.e., comorbidity) (1).
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Because of their perspective as a generalist, GPs
consider themselves to be specialists in comorbidity.
Patterns of comorbidity of depression and anxiety
disorders have been studied extensively, mainly
related to other psychiatric disorders (27). Patients
with a depressive disorder and patients with anxiety
have high distress levels and higher rates of other
psychiatric disorders (4,8,9).
Somatic comorbidity of patients with depression
has also been studied extensively, but studies are
almost always restricted to cardiovascular disorders
and chronic pain conditions (10,11). There are only
a few studies on somatic comorbidity in patients with
anxiety disorders. Byrne et al. reported a similar
prevalence of chronic medical conditions in patients
with and without anxiety disorders (4). However,
self-limiting minor illnesses have not been studied
within this framework. Furthermore, most studies
on comorbidity have a cross-sectional design and are
performed in specialized medical care (4,6).
Patients with depression and anxiety disorders are
high utilizers of medical care (4,8,12,13). Their high
healthcare utilization may reflect their level of
functional impairment and is related to their illness
behaviour (8,14). Their interpretation of common
symptoms and their attitude towards healthcare are
likely to contribute to this high utilization of
healthcare (6).
As a result of this high attendance rate and illness
behaviour, we hypothesize that patients with depres-
sion and anxiety disorders are more likely to present
with minor illnesses. Therefore, our aim was to study
the association of depression and/or anxiety disor-
ders with minor illnesses within a 30-year time
frame.
Methods
We performed a historic cohort study in a general
practice database of about 13 500 patients, repre-
sentative of the general Dutch population with
regard to age and gender, in order to assess the
risk of a first episode of presenting minor illnesses in
patients with depression or anxiety disorder.
Continuous Morbidity Registration database
We used data from the Continuous Morbidity
Registration (CMR) Nijmegen database, a project
of the Department of Family Medicine of
the University of Nijmegen in the Netherlands
(1518). The database comprises a network of four
practices in the Nijmegen region that has recorded
all morbidity on an ongoing basis since 1971. In the
Dutch healthcare system, the general practitioner
has a defined list of patients and is the gatekeeper of
access to specialist medical care. Long-term data are
available for nearly all patients, including diagnoses
after referral (16). Every episode of illness is
registered according to the E-list (19) and the
International Classification of Health Problems in
Primary Care (ICHPPC-2) (20). In addition to
medical data, the following information is also
available: age, sex, socio-economic status (SES)
(low, middle, and high), and marital status. Over
many years, monthly meetings for all GPs involved
are held to discuss classification problems, to moni-
tor the application of diagnostic criteria, and to
discuss coding problems of hypothetical case his-
tories.
Selection of patients
We selected three groups of patients from the CMR
database.
Patients with depression. All patients classified with a
code for depressive illness between 1971 and 2000
were selected from the CMR database (n799).
Patients younger than 18 years at the time of their
initial diagnosis of depression were excluded. Pa-
tients with a diagnosis of anxiety disorder prior to
the diagnosis of depression were included in the
group of patients with anxiety disorder.
Patients with anxiety disorder. We selected patients
diagnosed with an anxiety disorder between 1971
and 2000 (n153). Patients younger than 18 years
at the time of the first diagnosis of anxiety disorder
were excluded. Patients with a diagnosis of depres-
sion prior to the diagnosis of anxiety disorder were
included in the group of patients with depression.
The code for anxiety disorder also includes panic
disorder and phobia.
Control group. The control group was selected from
all remaining patients. By using propensity-score
matching, a control for each patient with depression
or anxiety disorder was drawn from this group (21).
For each control subject, a dummy ‘‘date of diag-
nosis’’ was used to equal the date of diagnosis of the
patients with their matched controls (22). Controls
therefore had to be present in the CMR database at
the time of the diagnosis of depression or anxiety
disorder of the matched patient. This dummy ‘‘date
of diagnosis’’ marked the start of the observation
period for the controls. Patients and controls were
matched for age, sex, SES, practice site, and date of
diagnosis.
























































Follow-up of patients with depression and anxiety
disorder started on the date of diagnosis of the first
episode of depression or anxiety disorder. Follow-up
ended on the date the patient left the CMR database
or at the end of the study (January 2000). These data
were censored.
Minor illnesses
Data on minor illnesses were collected over the
period of 1 year prior to the diagnosis until the end
of the study. For minor illnesses, we assessed three
prevalent categories: skin, musculoskeletal, and re-
spiratory disorders (23). Skin disorders included
infections of the skin, other diseases of the skin,
nails, and hair. Minor illnesses of the musculoskele-
tal system included myalgia, low-back pain, bursitis,
and tennis elbow. Respiratory disorders included,
among others, common cold, tonsillitis, and upper-
airway symptoms.
It should be mentioned that we did not study the
frequency of presentation of the minor illnesses but
the numbers of patients with a diagnosis of a minor
illness within the time frame.
Statistical methods
Our analyses primarily involved comparing patients
with depression with their matched controls and
comparing patients with anxiety disorder with their
matched controls. Statistical analyses were con-
ducted using SAS.
In our propensity-score matching procedure, we
first used a logistic regression model to predict the
propensity of having depression or anxiety disorder,
using individual characteristics such as age, sex,
SES, practice site, and date of diagnosis. After
balancing covariates in the propensity-score model,
a matching algorithm was used with a 1:1 matching
from best to next best for the outcome model. Best
matches were defined as those with the highest digit
match (0.00001) on the propensity score (22). The
algorithm proceeded sequentially to the lower digit
match. The lowest allowable digit match was 0.1. To
test whether the matching procedure resulted in
comparable groups, the chi-square test and Stu-
dent’s t test were used. All p values are two-tailed.
Descriptive statistics were calculated for the minor
illnesses 1 year prior to the diagnoses. The chi-
square test was used for testing differences in
occurrence of minor illnesses between patients and
controls. Cox proportional hazard analysis was used
to assess the risk of a first episode of minor illnesses
in patients with depression or anxiety disorder
compared to controls. Survival curves were drawn
and hazard ratios (HR) are presented with 95%
confidence intervals (CI). Survival curves were
calculated for patients and controls for minor ill-
nesses during the observation period after the
diagnosis of depression or anxiety disorder. Patients
with one of the three types of minor illnesses in the
year before the diagnosis of depression or anxiety
disorder were excluded from the (prospective) sur-
vival analysis because some of these minor illnesses
can have a chronic or recurrent course. Risks
differences of minor illnesses between patients and
controls were adjusted for age, sex, socio-economic
status, and practice site. We calculated the hazard
ratios and the 95% CI. All p values are two-tailed,
and p values of 0.05 or less were considered
statistically significant.
Results
In the CMR database, we identified 799 patients
with a depression disorder and 153 with an anxiety
disorder. The mean duration of follow-up was
11.9 years in the patients with a depression and 8.9
years in the patients with an anxiety disorder. The
characteristics of the patients of both groups and
their controls are comparable (Table I). In Table II,
morbidity is presented with respect to the minor
illnesses of all patients in the year before the
diagnosis of depression or anxiety disorder. Within
this time frame, significantly more patients with
depression or anxiety disorder compared to controls









Female, n (%) 529 (66.2) 534 (67.1) 102 (66.7) 102 (66.7)
Age, years (mean, SD) 45.9 (16.2) 45.7 (16.1) 39.6 (14.5) 39.4 (14.6)
Socio-economic status
low, n (%) 370 (46.3) 370 (46.5) 66 (43.1) 66 (43.1)
middle, n (%) 339 (42.4) 349 (43.8) 62 (40.5) 63 (41.2)
high, n (%) 90 (11.3) 77 (9.7) 25 (16.3) 24 (15.7)
Duration of follow-up,
years (mean, SD)
11.9 (9.8) 12.6 (9.9) 8.9 (7.2) 9.3 (6.0)
























































presented with minor illnesses to the GP, the only
exception being patients with musculoskeletal mor-
bidity in patients with anxiety disorder. The pre-
valence of minor illnesses in the years following the
initial diagnosis of depression and anxiety disorder
shows that significantly more patients with depres-
sion than controls were diagnosed with skin, muscu-
loskeletal, and respiratory morbidity (Table III). In
patients with an anxiety disorder, we only found a
significant association for musculoskeletal morbidity.
We adjusted the association of depression and
anxiety disorder with minor illnesses for age, sex,
socio-economic status, and practice site (Table IV).
A diagnosis of depression was statistically signifi-
cantly associated with presenting skin, musculoske-
letal, and respiratory morbidity. An anxiety disorder
was statistically significantly associated with present-
ing skin and musculoskeletal morbidity, but not with
presenting respiratory morbidity.
The proportions of patients presenting with a
specific minor illness in a 1-, 5-, or 10-year time
frame after diagnosis are presented in Table V.
Within the whole time frame, we found that more
patients with depression as well as more patients with
anxiety, compared to their controls, presented minor
illnesses to their GP. Even 10 years after the diagnosis
of depression or anxiety disorders, these differences
between patients and controls were evident.
Discussion
The results of this study provide new insights into
the presentation of minor illnesses by patients with
depressive and anxiety disorders. Compared to
controls, more patients with depression present
skin, musculoskeletal, and respiratory disorders in
the year before and in the years following the initial
diagnosis of depression. A slightly different pattern
of comorbidity is found in patients with anxiety:
compared to controls, more patients present skin
and respiratory disorders in the year before the initial
diagnosis, and more patients present musculoskele-
tal disorders in the years after the diagnosis of
anxiety disorder. These differences between patients
and their controls persist even 10 years after the
diagnosis of depression or anxiety disorder. Further-
more, depression is associated with presenting all
three types of minor illnesses during study, whereas
anxiety disorder is only associated with presenting
skin and musculoskeletal morbidity.
The strength of this study is the long follow-up
period. For some patients, this was even as long as
30 years. Moreover, we did not study prevalence in
the population but patients presenting their pro-
blems to the general practitioner. Therefore, the
symptoms were apparently relevant enough for the
patient to consult their GP and for the GP to register
them separately from the diagnosis of depression or
anxiety disorder. The data of the presented morbid-
ity are a reflection of daily practice and have a
demonstrated reliability and validity (17). This is
important because most studies on depression and
anxiety are based on questionnaires or diagnostic
interviews in which recall bias and patients’ mis-
interpretation of questions appear (24,25).
One of the limitations of the study is inter-doctor
variation in the diagnosis of depression or anxiety. We
assume this to be small because criteria for diagnosis
are discussed in monthly meetings, where the appli-
cation of diagnostic criteria is monitored (15,16).
However, neither ‘‘over-registration’’ nor ‘‘under-
registration’’ can be ruled out. We used the propen-
sity-score matching procedure to match patients and
controls. However, this method only reduces bias in









Skin, n (%) 98 (12.3)** 63 (7.9) 24 (15.7)* 10 (6.5)
Musculoskeletal, n (%) 212 (26.5)** 152 (19.1) 39 (25.5) 31 (20.3)
Respiratory, n (%) 237 (29.7)** 180 (22.6) 42 (27.5)** 13 (8.5)
*pB0.05, **pB0.01.
Table III. Skin, musculoskeletal, and respiratory morbidity in years after the diagnosis of depression or anxiety disorder.
Patients with depression Controls Patients with anxiety disorder Controls
Skin, n (%) 377 (53.8)** 337 (46.0) 68 (52.7) 64 (44.8)
Musculoskeletal, n (%) 411 (70.0)* 414 (64.3) 76 (66.7)* 65 (53.3)
Respiratory, n (%) 369 (65.7)** 363 (58.9) 58 (52.3) 68 (58.6)
* pB0.05, ** pB0.01.
























































certain patient characteristics (year of diagnosis,
gender, age, practice site, and SES) (26). It is worth
mentioning that we did not demonstrate a causal
pathway between mental health problems and minor
illnesses. We only describe a statistically significant
association between them.
Several studies report on the number of somatic
symptoms and prevalence rates of chronic diseases
(e.g., diabetes and cardiovascular disorders) in pa-
tients with and without anxiety disorders (4,6). These
studies report an association between clinical comor-
bidity and the specific condition of anxiety disorder.
In patients with depression, high prevalence rates of
pain-related medical problems are reported as well as
high prevalence rates of cardiovascular diseases
(10,11,27). To the best of our knowledge, there are
no studies reporting the prevalence of minor illness in
patients with a depression or anxiety disorder.
Our findings of high rates of minor illnesses in
patients with depression or anxiety can be explained
by both patient-related and physician-related factors.
Physicians might detect and register minor illnesses
more easily, as patients with depressive or anxiety
disorders attend their GP more often than controls.
Why more patients with depression or anxiety
disorder consult their GP for minor illnesses, how-
ever, is not clear. We hypothesize two mechanisms.
Firstly, depression and anxiety are often associated
with psychological distress (28). The symptoms
associated with stress may lead to greater somatic
awareness, to sensitization to symptoms, and, finally,
to more stress-related symptoms, with help-seeking
behaviour as a consequence (29,30). Secondly, there
is increasing evidence of altered pathophysiological
mechanisms in patients with mental health disor-
ders. Physical and emotional stress results in an
alteration of hormonal balance, especially in the
hypothalamus-pituitary-adrenal (HPA) axis, and
influences the immunological system (31). These
hormonal and immunological processes might be an
explanation for the vulnerability of these patients for
a range of minor illnesses (such as infectious
diseases) (6,31).
In conclusion, our analysis of the CMR database
for the relationship of mental health disorders and the
Table IV. Results of Cox proportional hazard analysis: hazard of
minor illnesses (skin, musculoskeletal, and respiratory) in years
after the diagnosis of depression or anxiety disorder.
Minor illnesses Hazard ratio 95% CI P value
Patients with depression
Skin 1.40 1.211.63 B0.0001
Musculoskeletal 1.30 1.141.50 B0.001
Respiratory 1.47 1.271.71 B0.0001
Patients with anxiety disorder
Skin 1.54 1.092.19 B0.05
Musculoskeletal 1.96 1.392.76 B0.0001
Respiratory 1.22 0.841.75 NS
Hazards for diagnosis of minor illnesses are adjusted for the year
of diagnosis, gender, age, practice site, and socio-economic status.
CI: confidence interval; NS: not significant.
Table V. Percentage of patients (95% confidence intervals) presenting a minor illness to their GP within 1, 5, or 10 years after the diagnoses
of depression or anxiety disorder.
Depression Controls Anxiety Controls
1 year after diagnosis
Skin 11.4 (9.013.8) 8.1 (6.110.1) 9.1 (4.014.2) 7.9 (3.412.4)
Musculoskeletal 20.8 (17.424.1) 18.0 (15.021.0) 18.6 (11.225.9) 10.1 (4.715.5)
Respiratory 24.1 (20.627.8)* 16.4 (13.519.4) 21.8 (13.929.6) 14.1 (8.220.0)
2 years after diagnosis
Skin 21.2 (18.124.4)* 13.3 (10.815.9) 18.5 (11.325.7) 20.3 (13.427.2)
Musculoskeletal 37.3 (33.241.4) 34.2 (30.438.0) 38.2 (28.747.7)* 20.7 (13.328.1)
Respiratory 39.0 (34.743.2)* 28.7 (25.032.4) 34.1 (24.943.3) 23.5 (16.330.8)
5 years after diagnosis
Skin 40.3 (36.344.2)* 29.6 (26.133.2) 49.0 (39.158.9) 36.0 (27.644.3)
Musculoskeletal 63.1 (58.767.4) 55.3 (51.159.5) 65.8 (55.875.8)* 44.6 (35.254.0)
Respiratory 61.6 (57.266.0)* 48.4 (44.252.7) 48.9 (38.659.2) 39.6 (31.148.1)
10 years after diagnosis
Skin 59.7 (55.364.0)* 47.4 (43.151.5) 69.5 (58.780.3) 51.6 (41.961.3)
Musculoskeletal 82.4 (78.586.3)* 73.7 (69.577.9) 85.2 (75.694.7)* 59.2 (48.769.6)
Respiratory 75.8 (71.480.1)* 65.7 (61.270.2) 66.4 (54.178.8) 59.2 (48.769.7)
*Statistically significant.
























































presentation of minor illnesses over a 30-year time
frame shows that depression and anxiety disorders
are associated with the presentation of minor illnesses
both in the year before the diagnosis of depression or
anxiety as well as in the years after these diagnoses.
The nature of the help-seeking behaviour, cognitive
and emotional processes, or underlying stress in
patients might account for the development of mental
health disorders and susceptibility to diseases. The
results of this first longitudinal study raise a number
of interesting questions regarding the nature of the
relationship between mental health problems and
minor illnesses and its consequences for patients with
a depression or anxiety disorder.
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